
DocGo (DCGO) Stock Forecast & Price Target
DocGo (DCGO) Analyst Ratings
Bulls say
DocGo is a growing company with a focus on providing innovative and unique healthcare services through its Mobile Health and Transportation Services segments. While there were some setbacks in 2Q'26 with an adjusted EBITDA miss and lowered outlook, the company is actively working to improve its profitability and expects to exit the year with a positive adjusted EBITDA run rate. Additionally, the recent acquisition of Hicuity Health provides DocGo with a profitable virtual care business and added liquidity for potential future growth opportunities. Although there are some concerns about scalability of its mobile health offerings, the company's organic revenue growth and focus on right-sizing its business are positive indicators for its future success.
Bears say
DocGo is experiencing declines in its Mobile Health Service segment, which generates a majority of its revenue, leading to a decrease in the company's overall revenue. While the recent acquisition of Hicuity Health may provide some potential for growth and cost synergies, there are concerns about the assumption of the company's debt and the potential impact of COVID-19 on its testing revenue. With a low target multiple and uncertainty regarding future growth prospects, there are fundamental risks to the company's financial performance, leading to a negative outlook.
This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.
DocGo (DCGO) Analyst Forecast & Price Prediction
Start investing in DocGo (DCGO)
Order type
Buy in
Order amount
Est. shares
0 shares